End-of-day quote
Other stock markets
|
||
- HKD | - |
Apr. 17 | BeiGene to Award Shares Worth $15 Million to 11 Directors | MT |
Apr. 11 | Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech | MT |
Sales 2024 * | 3.08B 24.13B | Sales 2025 * | 3.93B 30.74B | Capitalization | 13.53B 106B |
---|---|---|---|---|---|
Net income 2024 * | -892M -6.99B | Net income 2025 * | -358M -2.8B | EV / Sales 2024 * | 3.91 x |
Net cash position 2024 * | 1.48B 11.61B | Net cash position 2025 * | 1.13B 8.86B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
-15.2
x | P/E ratio 2025 * |
-40
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
+0.18% | 13.28B | |
+19.90% | 10.85B | |
-23.23% | 8.4B |